Disfunción eréctil en pacientes con hipertensión arterial en atención primaria

Abstract

Objective: Estimate the frequency of erectile dysfunction in patients with hypertension and associated variables, the degree of control, cardiovascular risk and the impact on quality of life. Material and methods: Observational study of prevalence in men with essential hypertension. Sociodemographic and comorbidity variables were collected from each patient, degree of control of essential hypertension and treatment, cardiovascular risk and metabolic syndrome. The erectile dysfunction was diagnosed by the International Index of Erectile Function (IIEF-15). Quality of life questionnaires were carried out in essential hypertension (MINICHAL), and the international scale of prostatic symptoms (IPSS). Results: The study included 262 hypertensive men with an average of 65.84 years of age. Erectile dysfunction was presented in 46.1%, being in 54.9% of severe degree. An independent association was found between erectile dysfunction and the variables: age, Charlon index, dyslipidemia, benign prostatic hypertrophy, diastolic blood pressure, years of diagnosis of hypertension, number of treatments, Regicor and Framingham-Wilson, pathological cardiopulmonary auscultation, glycemia, creatinine and glutamic pyruvic transaminase (GPT), glomerular filtration through the MDRD formula, filling symptomatology (IPSS) and somatic manifestations (MINICHAL). Conclusions: Erectile dysfunction is significantly associated with age, dyslipidemia, benign prostatic hypertrophy and metabolic syndrome.